Short-Term Evaluation of the AcrySof Angle-Supported Phakic Intraocular Lens: Visual Performance, Intraocular Pressure and Endothelial Cell Counts

Objectives: The aim of this study was to evaluate the visual performance, intraocular pressure and the endothelial cell density changes after implantation of the AcrySof angle-supported PIOL for the correction of moderate to high myopia.Patients and Methods: This study comprised patients with moderate to high myopia ranging from –6.0 D to –16.50 D who had implantation of the AcrySof angle supported pIOL. Outcome measures included uncorrected visual acuity (UCVA), best spectacle corrected visual acuity (BSCVA), safety, predictability and endothelial cell density (ECD).Results: Of the 32 eyes that were enrolled in the statistics the UCVA was 0.3 LogMAR (20/40, 6/12) or better in 62.5% and 0.2 LogMAR (20/32, 6/9) or better in 25% of the eyes. The BSCVA was 0.3 LogMAR (20/40, 6/12) or better in 88% and 0.2 LogMAR (20/32, 6/9) or better in 72% of the eyes. The mean percentage loss of the corneal endothelium at 1- month post operative was 5% and at 6 months was 0.1%.Conclusion: The AcrySof angle-supported PIOL provided favorable refractive correction, predictability and acceptable safety in patients with moderate to high myopia.